Human and Machine: A New Standard in Pharmacovigilance - Qinecsa

Human and Machine: A New Standard in Pharmacovigilance

Qinecsa CEO, Adam Sherlock, has been featured in Pharma Tech Outlook Europe’s latest issue, where he discusses how turning pharmacovigilance from a reactive function into a strategic advantage has become a competitive necessity.

With a singular focus on drug safety, Qinecsa combines advanced technologies with expert human insight to help manage complexity, ensure compliance, and drive better outcomes across every stage of the product lifecycle.

Read article

Recent Articles

The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?

Embracing quantitative signal detection methods as a smaller MAH

Real-Time Safety Signals Drive Continuous PV Insight

From Complaint Handling to Active Surveillance

Continuous Safety Surveillance for Medical Devices

Are patient outcomes getting lost in safety data complexity?

Previous Powering the Pharmacovigilance Engine: Why AI’s Role is Pivotal Now

Next AI Encompassing: From Soaring Caseloads to Broadened Biopharma Territory